|
|
|
|
| LEADER |
00694nam a2200193 4500 |
| 020 |
|
|
|
| 037 |
|
|
|
| 082 |
|
|
|a 030.660 REH.5a
|
| 100 |
|
|
|
| 245 |
|
|
|a A MULTIVOLUME COMPREHENSIVE TREATISE IN BIOTECHNOLOGY: VOLUME 5A; RECOMBINENT PROTEINS, MONOCLONAL ANTIBODIES AND THERAPEUTIC GENES
|h English
|
| 250 |
|
|
|a 2
|
| 260 |
|
|
|b WILEY INDIA PVT LTD
|c 2010
|
| 300 |
|
|
|
| 500 |
|
|
|
| 590 |
|
|
|
| 650 |
|
|
|a A MULTIVOLUME COMPREHENSIVE TREATISE IN BIOTECHNOLOGY VOLUME 5A; RECOMBINENT PROTEINS-- MONOCLONAL ANTIBODIES AND THERAPEUTIC GENES
|
| 942 |
|
|
|c REF
|
| 999 |
|
|
|c 132342
|d 132342
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 030_660000000000000_REH_5A
|7 0
|9 145802
|a BTY
|b BTY
|l 0
|o 030.660 REH.5a
|p BTY1845
|r 2019-10-24
|w 2019-10-24
|y REF
|